<DrugInformationSummary id="CDR0000768870"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Palbociclib works by blocking the activity of proteins called CDK4 and CDK6 that control how fast cells grow. Blocking these proteins may slow or stop the growth of cancer cells. Palbociclib is a type of targeted therapy drug called a kinase inhibitor. It is a small-molecule drug (a drug that can enter cells easily).</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/palbociclib">Palbociclib</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000454586">Palbociclib</TerminologyLink><GlossaryLink ref="CDR0000768872">palbociclib</GlossaryLink><USBrandNames><USBrandName>Ibrance</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>PAL-boh-SY-klib</TermPronunciation><MediaLink ref="CDR0000771240" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000771239" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0e6412f-50b4-4fd4-9364-62818d121a07&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Palbociclib</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0e6412f-50b4-4fd4-9364-62818d121a07&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Palbociclib
         is approved 
         to be used with other <GlossaryTermRef href="CDR0000348921" dictionary="Cancer.gov" audience="Patient">drugs</GlossaryTermRef> to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000444971" dictionary="Cancer.gov" audience="Patient">Breast cancer</GlossaryTermRef></Strong> that is <GlossaryTermRef href="CDR0000788029" dictionary="Cancer.gov" audience="Patient">hormone receptor positive</GlossaryTermRef> (HR+) and <GlossaryTermRef href="CDR0000774531" dictionary="Cancer.gov" audience="Patient">HER2 negative</GlossaryTermRef> (HER2-) and has spread. It is used:<ItemizedList Style="bullet" id="_5"><ListItem>with <GlossaryTermRef href="CDR0000306498" dictionary="Cancer.gov" audience="Patient">fulvestrant</GlossaryTermRef> in adults whose cancer has gotten worse after treatment with <GlossaryTermRef href="CDR0000045110" dictionary="Cancer.gov" audience="Patient">hormone therapy</GlossaryTermRef></ListItem><ListItem>with an <GlossaryTermRef href="CDR0000044232" dictionary="Cancer.gov" audience="Patient">aromatase inhibitor</GlossaryTermRef> in <GlossaryTermRef href="CDR0000045269" dictionary="Cancer.gov" audience="Patient">postmenopausal</GlossaryTermRef> women and in men  who have not been treated with hormone therapy</ListItem></ItemizedList></ListItem>
   
   </ItemizedList>
  <Para id="_4">Palbociclib
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Palbociclib</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/454586">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.27">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a615013.html">Palbociclib</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.28"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.29">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2022/medulloblastoma-nanoparticle-palbociclib-sapanisertib">Experimental Medulloblastoma Treatment Gets a Boost with Nanoparticles</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C49176">Find Clinical Trials for Palbociclib</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2015-02-10</DateFirstPublished><DateLastModified>2024-12-23</DateLastModified></DrugInformationSummary>
